Kriya Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Kriya Therapeutics's estimated annual revenue is currently $32.9M per year.
- Kriya Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Kriya Therapeutics has 212 Employees.
- Kriya Therapeutics grew their employee count by -13% last year.
Kriya Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and CEO | Reveal Email/Phone |
2 | CMO | Reveal Email/Phone |
3 | SVP, Technical Development | Reveal Email/Phone |
4 | VP IP | Reveal Email/Phone |
5 | VP, Head Corporate Communications | Reveal Email/Phone |
6 | VP, Research and Development, Neurology | Reveal Email/Phone |
7 | SVP, Strategic Planning and Integration | Reveal Email/Phone |
8 | VP, Analytical Development | Reveal Email/Phone |
9 | VP Research and Development Metabolic Disease | Reveal Email/Phone |
10 | SVP, Technical Operations | Reveal Email/Phone |
Kriya Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Kriya Therapeutics?
Kriya Therapeutics is a transformative gene therapy company with the intent to expand gene therapy to broader disease indications leveraging in house manufacturing capabilities and novel therapeutic designs. Our mission is to identify, develop, and bring to market high-impact therapies that have the potential to improve the lives of patients with prevalent and severe chronic diseases. We target conditions where the underlying biology is well-understood, rationally designing one-time gene therapies to durably express therapeutic proteins within the appropriate human tissues. Our team has deep expertise in the field and includes former senior leadership from pioneering gene therapy companies and academic institutions. We use algorithmic tools, scalable infrastructure, and proprietary technology to optimize the efficacy and durability of our gene therapies – with a goal of transforming the treatment paradigm for some of the most serious and widespread diseases.
keywords:N/AN/A
Total Funding
212
Number of Employees
$32.9M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $34M | 213 | N/A | N/A |
#2 | $32.1M | 213 | -4% | $109.8M |
#3 | $29.9M | 214 | -15% | $74.2M |
#4 | $33.1M | 215 | 28% | N/A |
#5 | $33.3M | 221 | -6% | $34.8M |